Sigyn Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $2,455,317.

Profit Margin

Sigyn Therapeutics, Inc. (OTC:SIGY): Profit margin
2014 43.15K -387.54K -898.05%
2015 29.20K -2.69M -9224.88%
2016 1.80M -831.53K -46.08%
2017 1.28M -4.25M -331.05%
2018 28.34K -2.62M -9243.24%
2019 143.32K -3.12M -2183.82%
2020 0 -1.60M
2021 0 -3.40M
2022 0 -3.71M
2023 0 -4.14M

SIGY Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000143.32K28.34K1.28M1.80M29.20K43.15K
Cost of revenue
8.85K10.45K53611.3K35.66K9.71K512.38K1.03M9.93K25.25K
Gross profit
-8.85K-10.45K-536-11.3K107.65K18.63K771.79K770.91K19.27K17.90K
Operating exp.
Research and development
798.16K657.65K734.01K27.45K000000
Selling and marketing
392457070511.83K45.94K533.44K795.81K42.99K5.56K
Total operating expenses
2.45M2.14M2.00M916.43K625.61K1.02M3.20M1.48M2.27M405.44K
Operating income
-2.45M-2.14M-2.00M-916.43K-517.95K-1.00M-2.43M-710.2K-2.25M-387.54K
Other income (expenses), net
-1.69M-782.55K-996.40K-343.15K-2.79M-946.93K-1.41M-121.33K-80.13K0
Income before tax
-4.14M-2.92M-3.00M-1.25M-3.31M-2.30M-4.25M-831.53K-2.69M-387.54K
Income tax expense
0782.11K399.07K343.15K-183.11K800800300
Net income
-4.14M-3.71M-3.40M-1.60M-3.12M-2.62M-4.25M-831.53K-2.69M-387.54K
Earnings per share
Basic EPS
-3.77-0.09-0.09-0.22-5.78-6.04-13.54-114.92-11.77-2.08
Diluted EPS
-3.77-0.09-0.09-0.22-5.78-6.04-13.54-114.92-11.77-2.08
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source